These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2516584)

  • 1. Aromatase inhibition and experimental antitumor activity of FCE 24304, MDL 18962 and SH 489.
    di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T
    J Steroid Biochem; 1989; 34(1-6):431-4. PubMed ID: 2516584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of the irreversible aromatase inhibitor exemestane with atamestane and MDL 18962 in rats with DMBA-induced mammary tumours.
    Zaccheo T; Giudici D; Ornati G; Panzeri A; di Salle E
    Eur J Cancer; 1991; 27(9):1145-50. PubMed ID: 1835626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new irreversible aromatase inhibitor, 6-methylenandrosta-1,4-diene-3,17-dione (FCE 24304): antitumor activity and endocrine effects in rats with DMBA-induced mammary tumors.
    Zaccheo T; Giudici D; Lombardi P; di Salle E
    Cancer Chemother Pharmacol; 1989; 23(1):47-50. PubMed ID: 2491793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of aromatase activity and of endocrine-responsive tumor growth by 10-propargylestr-4-ene-3, 17-dione and its 17-propionate derivative.
    Zimniski SJ; Brandt ME; Covey DF; Puett D
    Steroids; 1987; 50(1-3):135-46. PubMed ID: 3504057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; Di Salle E
    Cancer Chemother Pharmacol; 1989; 25(2):95-8. PubMed ID: 2513137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
    Di Salle E; Giudici D; Ornati G; Briatico G; D'Alessio R; Villa V; Lombardi P
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):369-74. PubMed ID: 2257240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aromatase inhibitors, aminoglutethimide, and 4-hydroxyandrostenedione on cyclic rats and rats with 7,12-dimethylbenz(a)anthracene-induced mammary tumors.
    Wing LY; Garrett WM; Brodie AM
    Cancer Res; 1985 Jun; 45(6):2425-8. PubMed ID: 3921242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of a specific aromatase inhibitor, 1-methyl-androsta-1,4-diene-3,17-dione (atamestane), in female rats bearing DMBA-induced mammary tumors.
    Nishino Y; Schneider MR; Michna H; el Etreby MF
    J Steroid Biochem; 1989; 34(1-6):435-7. PubMed ID: 2533949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel irreversible aromatase inhibitors.
    di Salle E; Giudici D; Briatico G; Ornati G
    Ann N Y Acad Sci; 1990; 595():357-67. PubMed ID: 2375613
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro and in vivo studies with aromatase inhibitor 4-hydroxy-androstenedione.
    Brodie AM; Wing LY
    Steroids; 1987; 50(1-3):89-103. PubMed ID: 3504069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
    Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme inactivation by potential metabolites of an aromatase-activated inhibitor (MDL 18,962).
    Johnston JO; Wright CL; Holbert GW; Benson HD
    J Enzyme Inhib; 1990; 4(2):137-42. PubMed ID: 2098520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pregnant mare's serum gonadotropin-stimulated rat ovarian aromatase and its inhibition by 10-propargylestr-4-ene-3,17-dione.
    Brandt ME; Puett D; Covey DF; Zimniski SJ
    J Steroid Biochem; 1988 Sep; 31(3):317-24. PubMed ID: 3419162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human trophoblast xenografts in athymic mice: a model for peripheral aromatization.
    Johnston JO; Wright CL; Shumaker RC
    J Steroid Biochem; 1989 Oct; 33(4A):521-9. PubMed ID: 2811362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological characterization of 10-(2-propynyl) estr-4-ene-3, 17-dione (MDL 18,962), an enzyme-activated inhibitor of aromatase.
    Johnston JO
    Steroids; 1987; 50(1-3):105-20. PubMed ID: 2847370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of combined treatment with the aromatase inhibitor exemestane and tamoxifen on DMBA-induced mammary tumors in rats.
    Zaccheo T; Giudici D; Di Salle E
    J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):677-80. PubMed ID: 8476783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of the aromatase inhibitor FCE 24928 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone.
    Zaccheo T; di Salle E
    Cancer Chemother Pharmacol; 1993; 31(4):308-12. PubMed ID: 8422695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aromatase and 5 alpha-reductase inhibitors.
    Di Salle E; Briatico G; Giudici D; Ornati G; Zaccheo T; Buzzetti F; Nesi M; Panzeri A
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):289-94. PubMed ID: 8043491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo.
    Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH; Marcotte PA; Robinson CH
    Steroids; 1981 Dec; 38(6):693-702. PubMed ID: 7336466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.